title: Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges.
abstract: Individuals with attention-deficit/hyperactivity disorder (ADHD) show pervasive impairments across family, peer, and school or work functioning that may extend throughout the day. Psychostimulants are highly effective medications for the treatment of ADHD, and the development of long-acting stimulant formulations has greatly expanded the treatment options for individuals with ADHD. Strategies for the formulation of long-acting stimulants include the combination of immediate-release and delayed-release beads, and an osmotic-release oral system. A recent development is the availability of the first prodrug stimulant, lisdexamfetamine dimesylate (LDX). LDX itself is inactive but is cleaved enzymatically, primarily in the bloodstream, to release d-amphetamine (d-AMP). Several clinical trials have demonstrated that long-acting stimulants are effective in reducing ADHD symptoms compared with placebo. Analog classroom and simulated adult workplace environment studies have shown that long-acting stimulants produce symptom reduction for at least 12 h. Long-acting stimulants exhibit similar tolerability and safety profiles to short-acting equivalents. While variations in gastric pH and motility can alter the availability and absorption of stimulants released from long-acting formulations, the systemic exposure to d-AMP following LDX administration is unlikely to be affected by gastrointestinal conditions. Long-acting formulations may also improve adherence and lower abuse potential compared with their short-acting counterparts. The development of long-acting stimulants provides physicians with an increased range of medication options to help tailor treatment for individuals with ADHD.
authors.affiliation: Children's Developmental Center, Winter Park, FL, USA.
authors.forename: Frank A
authors.initials: FA
authors.lastname: López
authors.forename: Jacques R
authors.initials: JR
authors.lastname: Leroux
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000009:adverse effects / Q000627:therapeutic use*; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000069478:Lisdexamfetamine Dimesylate; D055118:Medication Adherence; D011355:Prodrugs / Q000627:therapeutic use
chemical_list: D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D011355:Prodrugs; D000069478:Lisdexamfetamine Dimesylate; D003913:Dextroamphetamine
references.citation: P T. 2009 Dec;34(12):678-94
references.pmid: 20140141
references.citation: Pediatrics. 2007 Dec;120(6):e1494-501
references.pmid: 18055666
references.citation: Pediatrics. 2001 Jun;107(6):E105
references.pmid: 11389303
references.citation: Eur Child Adolesc Psychiatry. 2006 Dec;15(8):476-95
references.pmid: 16680409
references.citation: J Am Acad Child Adolesc Psychiatry. 2008 Sep;47(9):994-1009
references.pmid: 18580502
references.citation: Clin Ther. 2010 Feb;32(2):252-64
references.pmid: 20206783
references.citation: J Clin Psychiatry. 2007 Feb;68(2):268-77
references.pmid: 17335326
references.citation: Biol Psychiatry. 2006 May 1;59(9):829-35
references.pmid: 16373066
references.citation: Pharmacotherapy. 2005 Jul;25(7):909-17
references.pmid: 16006269
references.citation: Clin Pediatr (Phila). 2011 Apr;50(4):308-20
references.pmid: 21436147
references.citation: J Clin Psychopharmacol. 2009 Jun;29(3):239-47
references.pmid: 19440077
references.citation: J Clin Psychiatry. 2010 Jun;71(6):754-63
references.pmid: 20051220
references.citation: Clin Ther. 2007 Mar;29(3):450-63
references.pmid: 17577466
references.citation: N Engl J Med. 2011 Nov 17;365(20):1896-904
references.pmid: 22043968
references.citation: Atten Defic Hyperact Disord. 2010 Dec;2(4):213-20
references.pmid: 21258431
references.citation: Am J Psychiatry. 2003 Nov;160(11):1909-18
references.pmid: 14594733
references.citation: J Atten Disord. 2011 May;15(4):286-94
references.pmid: 20495161
references.citation: Pediatrics. 2002 Aug;110(2 Pt 1):258-66
references.pmid: 12165576
references.citation: J Child Adolesc Psychopharmacol. 2008 Feb;18(1):11-24
references.pmid: 18294084
references.citation: J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):501-510
references.pmid: 19307987
references.citation: Clin Drug Investig. 2011;31(6):357-70
references.pmid: 21539403
references.citation: Pediatrics. 2011 Nov;128(5):1007-22
references.pmid: 22003063
references.citation: Arch Pediatr Adolesc Med. 2005 Jun;159(6):572-8
references.pmid: 15939858
references.citation: Biol Psychiatry. 2007 Nov 1;62(9):970-6
references.pmid: 17631866
references.citation: Am J Manag Care. 2009 May;15(5 Suppl):S141-50
references.pmid: 19601689
references.citation: Pediatrics. 2001 Oct;108(4):883-92
references.pmid: 11581440
references.citation: MedGenMed. 2006 Oct 05;8(4):4
references.pmid: 17415287
references.citation: Child Adolesc Psychiatry Ment Health. 2009 Jun 09;3(1):17
references.pmid: 19508731
references.citation: Am J Psychiatry. 2007 Jun;164(6):942-8
references.pmid: 17541055
references.citation: J Atten Disord. 2012 Nov;16(8):697-705
references.pmid: 22084448
references.citation: CNS Drugs. 2010 Dec;24(12):1009-25
references.pmid: 21090837
references.citation: Pediatrics. 2004 Nov;114(5):e541-7
references.pmid: 15520087
references.citation: J Clin Psychiatry. 2005 Feb;66(2):253-9
references.pmid: 15705013
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1015-1027
references.pmid: 17667480
references.citation: Postgrad Med. 2009 Sep;121(5):11-9
references.pmid: 19820270
references.citation: Child Adolesc Psychiatry Ment Health. 2008 Oct 28;2(1):31
references.pmid: 18957105
references.citation: J Am Acad Child Adolesc Psychiatry. 2011 Apr;50(4):395-405
references.pmid: 21421179
references.citation: Arch Gen Psychiatry. 2003 Feb;60(2):204-11
references.pmid: 12578439
references.citation: Neuropsychiatr Dis Treat. 2010 Jun 24;6:317-27
references.pmid: 20628632
references.citation: J Child Adolesc Psychopharmacol. 2007 Oct;17(5):675-88
references.pmid: 17979587
references.citation: Child Adolesc Psychiatry Ment Health. 2011 Nov 04;5(1):35
references.pmid: 22054243
references.citation: CNS Spectr. 2006 Aug;11(8):625-39
references.pmid: 16871129
references.citation: Curr Psychiatry Rep. 2008 Oct;10(5):424-31
references.pmid: 18803917
references.citation: J Pediatr. 2005 Sep;147(3):348-54
references.pmid: 16182674
references.citation: J Clin Pharmacol. 2008 Mar;48(3):293-302
references.pmid: 18285619
references.citation: J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):684-91
references.pmid: 12921476
references.citation: J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121-31
references.pmid: 21488750
references.citation: J Psychopharmacol. 2009 Jun;23(4):419-27
references.pmid: 19329547
references.citation: J Atten Disord. 2008 Sep;12(2):115-25
references.pmid: 18192623
references.citation: J Psychiatr Pract. 2011 Jul;17(4):241-50
references.pmid: 21775825
references.citation: J Psychopharmacol. 2009 Jun;23(4):410-8
references.pmid: 18635707
references.citation: Postgrad Med. 2010 Jan;122(1):184-91
references.pmid: 20107302
references.citation: Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90
references.pmid: 16389216
references.citation: Behav Brain Funct. 2010 Jun 24;6:34
references.pmid: 20576091
references.citation: Int J Clin Pharmacol Ther. 2002 Apr;40(4):175-84
references.pmid: 11996212
references.citation: CNS Drugs. 2003;17(2):117-31
references.pmid: 12521359
references.citation: Pediatrics. 1987 Oct;80(4):491-501
references.pmid: 3658567
references.citation: Circulation. 2008 May 6;117(18):2407-23
references.pmid: 18427125
references.citation: CNS Drugs. 2008;22(7):603-11
references.pmid: 18547128
references.citation: J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31
references.pmid: 18174822
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921
references.pmid: 17581453
references.citation: J Child Adolesc Psychopharmacol. 1992 Winter;2(4):279-90
references.pmid: 19630610
references.citation: Pharmacotherapy. 2002 Nov;22(11):1405-15
references.pmid: 12432966
references.citation: J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1268-76
references.pmid: 11699800
references.citation: J Am Acad Child Adolesc Psychiatry. 2006 Feb;45(2):192-202
references.pmid: 16429090
references.citation: J Am Acad Child Adolesc Psychiatry. 2001 May;40(5):525-9
references.pmid: 11349696
references.citation: Curr Med Res Opin. 2010 Apr;26(4):977-89
references.pmid: 20178404
references.citation: Lancet. 2005 Jul 16-22;366(9481):237-48
references.pmid: 16023516
references.citation: J Atten Disord. 2012 Feb;16(2):128-37
references.pmid: 20837983
references.citation: J Clin Pharmacol. 2007 Dec;47(12):1476-88
references.pmid: 17962423
references.citation: Pediatrics. 1990 Aug;86(2):226-37
references.pmid: 2196522
references.citation: J Clin Psychiatry. 2006 Apr;67(4):524-40
references.pmid: 16669717
references.citation: J Clin Pharmacol. 2010 Sep;50(9):1001-10
references.pmid: 20173084
references.citation: J Am Acad Child Adolesc Psychiatry. 2002 May;41(5):530-7
references.pmid: 12014785
references.citation: J Child Adolesc Psychopharmacol. 2005 Aug;15(4):637-54
references.pmid: 16190795
references.citation: BMC Med. 2011 Jun 10;9:72
references.pmid: 21658285
references.citation: J Child Psychol Psychiatry. 2009 Jan;50(1-2):180-93
references.pmid: 19220601
references.citation: Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37
references.pmid: 21042924
references.citation: J Clin Pharmacol. 2007 Jun;47(6):760-6
references.pmid: 17395894
references.citation: Pediatrics. 2006 Sep;118(3):1215-9
references.pmid: 16951018
references.citation: JAMA. 2011 Dec 28;306(24):2673-83
references.pmid: 22161946
references.citation: J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):673-83
references.pmid: 12921475
references.citation: Paediatr Drugs. 2003;5(8):545-55
references.pmid: 12895137
references.citation: Pediatrics. 2004 Mar;113(3 Pt 1):e206-16
references.pmid: 14993578
references.citation: Biol Psychiatry. 2008 May 15;63(10):981-9
references.pmid: 18206857
references.citation: Psychol Med. 2007 Jan;37(1):97-107
references.pmid: 16938146
references.citation: Am J Psychiatry. 2006 Mar;163(3):387-95
references.pmid: 16513858
references.citation: Clin Ther. 2006 Feb;28(2):266-79
references.pmid: 16678648
references.citation: World J Biol Psychiatry. 2013 May;14(4):268-81
references.pmid: 22106853
references.citation: Expert Opin Pharmacother. 2011 Feb;12(2):315-24
references.pmid: 21226641
references.citation: Am J Psychiatry. 2006 Apr;163(4):716-23
references.pmid: 16585449
references.citation: J Clin Psychiatry. 2008 Sep;69(9):1364-73
references.pmid: 19012818
references.citation: Pediatrics. 2009 Jul;124(1):e75-80
references.pmid: 19564272